S100A5 and bladder transitional cell carcinoma: We selected four important immune checkpoints, including PD‐L1, CTLA‐4, PD‐1, and lymphocyte activation gene‐3 (LAG‐3), and found that S100A5 had the most exclusive association with these immune checkpoints in BLCA (Figure S3B–E, Supporting Information).